Vera Therapeutics (VERA) Minority Interest (2020 - 2021)

Vera Therapeutics (VERA) posted Minority Interest of $139.6 million for Q1 2021, little changed on a QoQ basis from $139.6 million in Q4 2020.

Vera Therapeutics (VERA) Minority Interest (2020 - 2021) Analysis & Trends

Vera Therapeutics' Minority Interest history runs 2 years deep, the most recent figure standing at $139.6 million for Q1 2021.

Quarterly Minority Interest changed N/A year-over-year to $139.6 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $139.6 million (changed N/A YoY) and the FY2020 annual result came in at $139.6 million, changed N/A from the prior year.
Minority Interest was $139.6 million for Q1 2021 at Vera Therapeutics, roughly flat from $139.6 million in the prior quarter.
Across five years, Minority Interest topped out at $139.6 million in Q4 2020 and bottomed at $139.6 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Vera Therapeutics	2.60 Bn	2.60 Bn	-

Download Data

Date	Value
Mar 31, 2021	139.58 Mn
Dec 31, 2020	139.58 Mn